| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
9,727 |
8,803 |
$525K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
5,748 |
5,232 |
$443K |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
7,538 |
6,984 |
$218K |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
2,746 |
2,519 |
$192K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
4,212 |
3,639 |
$86K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
2,962 |
2,786 |
$33K |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
318 |
295 |
$32K |
| 99202 |
Office or other outpatient visit for the evaluation and management of a new patient, straightforward |
320 |
309 |
$17K |
| 87811 |
Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) |
125 |
122 |
$3K |
| 87400 |
|
71 |
65 |
$1K |
| 87807 |
|
102 |
93 |
$766.34 |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
43 |
40 |
$346.84 |
| 81003 |
|
209 |
179 |
$250.08 |
| 99072 |
|
495 |
462 |
$0.00 |
| A9150 |
Non-prescription drugs |
43 |
34 |
$0.00 |
| 99000 |
|
14 |
14 |
$0.00 |